Stay updated on Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page
- Check5 days agoChange DetectedThe site revision displayed changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedSite update to revision v3.4.2; the funding/operating status notice has been removed and there are no changes to study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNotice banner warns that information may not be up to date due to a lapse in government funding and provides operating status links. The page revision changed from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check48 days agoChange DetectedA glossary toggle was added and QC-related labels were updated (Last Update Submitted that Met QC Criteria added; the previous 'met QC Criteria' label removed). The revision tag changes from v3.3.4 to v3.4.0 and the No FEAR Act data capitalization was adjusted.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page revision shows v3.3.4 replacing v3.3.3, with no substantive changes to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a dedicated Locations section showing the California site (San Francisco, UCSF). The footer label was updated from 'California Locations' to a general 'Locations' entry in revision v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & GM-CSF in Biliary Cancer Clinical Trial page.